Finished Product

RAN-811-CT

Human

Foot and Ankle

Orthobiologics

Procedure

Product

The IntraOsseous BioPlasty IOBP® technique is used to treat subchondral bone pathologies that are a result of acute or chronic injury, such as bone marrow lesions in the talus associated with persistent bone bruising or an insufficiency fracture.&nbsp;
The IOBP&nbsp;procedure encourages physiologic bone remodeling and repair through a core decompression of the lesion and a direct application of concentrated platelet-rich plasma (cPRP) from bone marrow aspirate (BMA) mixed with Allosync Pure DBM for biologic graft to support the subchondral bone.

IntraOsseous BioPlasty® Technique for Foot and Ankle

Child (D)

The IntraOsseous BioPlasty (IOBP) surgical technique is for the treatment of bone pathologies resulting from acute or chronic injury, including bone marrow lesions associated with insufficiency fractures, persistent bone bruises, osteoarthritis, and early stages of avascular necrosis. The IOBP® procedure treats these pathologies through a core decompression of the lesion and a direct application of platelet-rich plasma concentrate (cPRP) from bone marrow aspirate (BMA) using the Arthrex Angel® cPRP and bone marrow processing system. The IOBP procedure encourages physiologic bone remodeling and repair.

IntraOsseous BioPlasty® (IOBP) Technique

The IntraOsseous BioPlasty (IOBP) surgical technique is for the treatment of bone pathologies resulting from acute or chronic injury, including bone marrow lesions associated with insufficiency fractures, persistent bone bruises, osteoarthritis, and early stages of avascular necrosis.

Delivery Needle, 8G x 11 cm, Closed Tip